+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of nicergoline on the cardiovascular system of dogs and rats

Effects of nicergoline on the cardiovascular system of dogs and rats

Journal of Cardiovascular Pharmacology 3(4): 677-691

In pentobarbitalized closed-chest dogs, nicergoline (10--100 microgram/kg, i.v.) reduced blood pressure, heart rate, and splanchnic nerve activity. Intracisternal administration of nicergoline (3 microgram/kg) only reduced splanchnic nerve activity. In open-chest dogs, nicergoline reduced blood pressure, cardiac output, and total peripheral resistance but did not change heart rate. In pithed rats treated with a beta-adrenoceptor-blocking agent, nicergoline reduced the pressor responses to noradrenaline and adrenaline. Nicergoline slightly attenuated the pressor responses of dogs to noradrenaline and tyramine and, in addition, reversed the hypertension induced by adrenaline and dimethylphenylpiperazinium. Nicergoline (100 microgram/kg) increased the tachycardia induced in dogs by stimulation of the right cardiovascular nerve and prevented the inhibitory effect of clonidine on this response. However, nicergoline only partially antagonized the effect of clonidine once it was fully established. Nicergoline did not antagonize the hypotensive and bradycardic effects of clonidine when they were established. Nicergoline did not affect the vagally mediated bradycardia evoked by carotid nerve stimulation in beta-adrenoceptor-blocked dogs. The compound did not change blood pressure in Cl spinal cord transected dogs. In conclusion, nicergoline appears to decrease blood pressure by blocking alpha-adrenoceptors and, at least at some doses, by a central inhibition of the sympathetic tone. Nicergoline appears to be a preferential alpha 1-adrenoceptor-blocking agent.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 042960587

Download citation: RISBibTeXText

PMID: 6167799

DOI: 10.1097/00005344-198107000-00003

Related references

Nicergoline as a cardiovascular agent in old dogs. Essai d' utilisation de la nicergoline en geriatrie canine: 61, 1981

Effects of nicergoline on calcium and magnesium deposition in the central nervous system tissues of rats maintained on low-calcium diets. Journal of International Medical Research 20(6): 483-491, 1992

Centrally mediated cardiovascular effects of nicergoline in the dog compared to those of clonidine. European Journal of Pharmacology 117(1): 103-108, 1985

Comparison of the effects of adrafinil, propentofylline, and nicergoline on behavior in aged dogs. American Journal of Veterinary Research 61(11): 1410-1414, 2000

Behavioral pharmacological properties of nicergoline. Effects on gross-behavior in rats and monkeys and on DRL response, CER, and CAR in rats. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 87(2): 209-221, 1986

MMB4 DMS: cardiovascular and pulmonary effects on dogs and neurobehavioral effects on rats. International Journal of Toxicology 32(4 Suppl): 49s-58s, 2014

Effects of oxybutynin on the cardiovascular system in dogs. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 84(4): 395-406, 1984

Effects of kp 403 on cardiovascular system in anesthetized dogs. Japanese Journal of Pharmacology 55(Suppl. 1): 341P, 1991

The effects of nicergoline an alpha adrenoceptor blocking drug on ischemia and reperfusion induced arrhythmias in anesthetized dogs. British Journal of Pharmacology 84(Suppl.): 30P, 1985

Effects of muskrat on the cardiovascular system in anesthetized dogs. Zhongguo Zhongyao Zazhi 14(4): 49-51, 64, 1989

Effects of hypercapnia on the cardiovascular system of conscious dogs. Journal of Applied Physiology 25: 346-348, 1968

Effects of synthetic angiotensin on the cardiovascular system in dogs. Surgical Forum 12: 68-70, 1961

The effects of nicergoline on spontaneously hypertensive rats and their offspring. Clinical and Experimental Hypertension. Part A Theory and Practice 5(4): 613-624, 1983

The effects of nicergoline and other vaso active substances on molecular biological processes in the brain and their effects on the learning abilities of rats. Heidrich, H (Ed ) Proof Of Therapeutical Effectiveness Of Nootropic And Vasoactive Drugs: Advances in Clinical And Experimental Nicergoline Research Xi+258p Springer-Verlag New York, Inc : Secaucus, N J , Usa; Berlin, West Germany Illus Paper 119-130, 1985

Antihypertensive and cardiovascular effects of a new potassium channel opener, TCV-295, in rats and dogs. Journal of Cardiovascular Pharmacology 24(6): 929-936, 1994